Navigation Links
A trial to find out the effectiveness of biocides against Vespa velutina
Date:4/16/2013

The Monitoring Committee for the Asian hornet, the Vespa velutina, in which the Government of the Basque Autonomous Community (region), the Charter Provincial Councils, the Beekeeping sector and Neiker-Tecnalia are working together, will be taking steps aimed at controlling the Vespa velutina populations and minimizing their impact. This type of hornet is an invasive species from France that preys on bees and devastates beehives.

The Vespa velutina Monitoring Committee, which has been fighting to control this pest in the Basque Autonomous Community, has agreed to develop, through Neiker-Tecnalia, a controlled trial to assess the potential effectiveness on this insect of biocides tested in Chile for the Vspula germnica. This process will be carried out through the placing and controlled monitoring of baits, thus seeking to minimize the effects on other insect populations, birds and vertebrates.

Another of the steps will make it possible to find out the effect the Asian hornet is having on the viability and production of beehives by analysing the location of the Vespa velutina nests and determining its expansion and advances.

The Basque Government has initially earmarked 45,000 euros to fund these steps and has proposed action protocols with each of the parties involved in order to achieve progress.


'/>"/>

Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1

Related biology news :

1. Sea level rise: Jeopardy for terrestrial biodiversity on islands
2. Mummy CT scans show preindustrial hunter gatherers had clogged arteries
3. Human trials for Streptococcus A vaccine
4. Manchester patients take part in pioneering heart attack blood test trial
5. MSU launches groundbreaking drug trial in Africa
6. Major clinical trial finds no link between genetic risk factors and 2 top wet AMD treatments
7. VIB applies for second poplar field trial
8. Canada launches first gene therapy trial for Fabry disease
9. £35 million to support research for vital industrial sector
10. New marker of drug response may speed pace of lung cancer prevention trials
11. New tuberculosis drug trial begins in South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/9/2017)... -- The biomass boiler market report by Transparency Market ... globally in terms of revenue (US$ Mn) based on ... biomass boilers has been segmented on the basis of ... market based on feedstock type, has been segmented into ... crops, urban residues, and others. On the basis of ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... 22, 2017  UBM and the Massachusetts Medical ... extended partnership and the third annual Massachusetts Medtech Week. ... 21 st Annual MassMEDIC Conference held in ... 3-4, 2017. MassMEDIC will feature ... President and CEO, Scott Whitaker , at ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
Breaking Biology Technology: